Nuclear factor-kappaB p65 mediates tumor necrosis factor alpha-induced nuclear translocation of telomerase reverse transcriptase protein.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 12517770.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Sustained proliferation of cancer cells requires telomerase to maintain telomeres that regulate chromosomal stability and cellular mitosis. Expression of human telomerase reverse transcriptase (hTERT) catalytic subunit, which modulates telomerase activity, is regulated at both the transcriptional level and via phosphorylation by Akt kinase. Moreover, nuclear localization of hTERT is required to promote elongation of telomere sequences. In this study, we show for the first time that hTERT protein interacts directly with nuclear factor (NF)-kappaB p65 in MM.1S cells. Importantly, tumor necrosis factor alpha (TNFalpha) modulates telomerase activity by inducing translocation from the cytoplasm to the nucleus of hTERT protein bound to NF-kappaB p65. Conversely, a specific IkappaB kinase (IKK) inhibitor PS-1145, and a specific NF-kappaB nuclear translocation inhibitor SN-50, both block TNFalpha-induced hTERT nuclear translocation. These studies suggest that NF-kappaB p65 plays a pivotal role in regulating telomerase by modulating its nuclear translocation.
Medical subject headings
- NF-kappa B
- Telomerase
- Tumor Necrosis Factor-alpha